Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA).

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, de Morais, J, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

Preview

Text ADB-CHMINACA_TR_with Annexes and cover.pdf - Published Version Download (865kB) | Preview

Abstract

In accordance with Article 6 of Council Decision 2005/387/JHA on the information exchange,
risk assessment and control of new psychoactive substances.

Item Type:	Monograph (Technical Report)
Subjects:	Q Science > QD Chemistry R Medicine > RM Therapeutics. Pharmacology
Divisions:	Pharmacy and Biomolecular Sciences
Publisher:	European Monitoring Centre for Drugs and Drug Addiction
Date of acceptance:	25 September 2017
Date of first compliant Open Access:	3 January 2018
Date Deposited:	03 Jan 2018 11:30
Last Modified:	21 Jan 2022 15:16
URI:	https://ljmu-9.eprints-hosting.org/id/eprint/7766

View Item